China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Speaking at the 2026 J.P. Morgan Healthcare Conference, Hogan Lovells global regulatory partners Elizabeth Jungman and Brian ...

Resolving business-related disputes swiftly, protecting the legitimate rights of market participants, and nurturing a healthy ...